V

VYNE Therapeutics

72 employees

VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.

Basic info

pharmaceuticals

Pharmaceutical

Wound

Formulation

Topical

Skin

Health Care

Atopic Dermatitis

Therapeutics

Dermatology

Acne

Foam

Psoriasis

Rosacea

2003

$51M

from 11 investors over 11 rounds

V

VYNE Therapeutics raised $51M on July 18, 2017

Investors: Aisling Capital, venBio Partners, F-Prime Capital Partners, Bay City Capital, Vivo Capital, Novo Holdings and Presidio Partners

V

VYNE Therapeutics raised $45M on November 1, 2015

Investors: Presidio Partners, Vivo Capital and F-Prime Capital Partners

V

VYNE Therapeutics raised $14M on May 1, 2015

Investors: CMEA Capital